Schrodinger Gross Margin 2019-2024 | SDGR
Current and historical gross margin for Schrodinger (SDGR) over the last 10 years. The current gross profit margin for Schrodinger as of September 30, 2024 is %.
| Schrodinger Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2024-09-30 | $0.19B | $0.13B | 65.28% |
| 2024-06-30 | $0.20B | $0.13B | 65.67% |
| 2024-03-31 | $0.19B | $0.12B | 60.85% |
| 2023-12-31 | $0.22B | $0.14B | 65.44% |
| 2023-09-30 | $0.20B | $0.12B | 61.50% |
| 2023-06-30 | $0.19B | $0.12B | 59.79% |
| 2023-03-31 | $0.20B | $0.12B | 60.41% |
| 2022-12-31 | $0.18B | $0.10B | 55.80% |
| 2022-09-30 | $0.17B | $0.09B | 51.76% |
| 2022-06-30 | $0.16B | $0.08B | 50.31% |
| 2022-03-31 | $0.16B | $0.08B | 49.68% |
| 2021-12-31 | $0.14B | $0.07B | 47.10% |
| 2021-09-30 | $0.13B | $0.06B | 46.40% |
| 2021-06-30 | $0.12B | $0.06B | 51.24% |
| 2021-03-31 | $0.11B | $0.06B | 56.14% |
| 2020-12-31 | $0.11B | $0.06B | 59.26% |
| 2020-09-30 | $0.10B | $0.06B | 60.40% |
| 2020-06-30 | $0.10B | $0.06B | 60.00% |
| 2020-03-31 | $0.09B | $0.05B | 58.24% |
| 2019-12-31 | $0.09B | $0.05B | 58.14% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.644B | $0.217B |
| Schr?dinger Inc. provides computational platforms to accelerate drug discovery and materials design deployed by biopharmaceutical and industrial companies, academic institutions and government laboratories. Schr?dinger Inc. is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $9.855B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $7.039B | 179.00 |
| Inspire Medical Systems (INSP) | United States | $5.776B | 180.15 |
| Enovis (ENOV) | United States | $2.727B | 18.49 |
| IRhythm Technologies (IRTC) | United States | $2.722B | 0.00 |
| Privia Health (PRVA) | United States | $2.578B | 214.80 |
| Omnicell (OMCL) | United States | $2.158B | 70.59 |
| Azenta (AZTA) | United States | $2.106B | 112.71 |
| 10x Genomics (TXG) | United States | $1.925B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.744B | 0.00 |
| Phreesia (PHR) | United States | $1.215B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.701B | 0.00 |
| Standard BioTools (LAB) | United States | $0.685B | 0.00 |
| Talkspace (TALK) | United States | $0.578B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.560B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.546B | 94.60 |
| Health Catalyst (HCAT) | United States | $0.537B | 0.00 |
| TruBridge (TBRG) | United States | $0.268B | 78.04 |
| Pulmonx (LUNG) | United States | $0.255B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.223B | 0.00 |
| American Well (AMWL) | United States | $0.147B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.109B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.090B | 0.00 |
| HeartBeam (BEAT) | United States | $0.082B | 0.00 |
| 111 (YI) | China | $0.071B | 0.00 |
| CareCloud (CCLD) | United States | $0.051B | 0.00 |
| Zepp Health (ZEPP) | China | $0.047B | 0.00 |
| Outset Medical (OM) | United States | $0.047B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.042B | 0.00 |
| Movano (MOVE) | United States | $0.037B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.019B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.011B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |